0001077183-20-000024.txt : 20200228 0001077183-20-000024.hdr.sgml : 20200228 20200228175347 ACCESSION NUMBER: 0001077183-20-000024 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200219 FILED AS OF DATE: 20200228 DATE AS OF CHANGE: 20200228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pedulla Denise E CENTRAL INDEX KEY: 0001804602 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35756 FILM NUMBER: 20672926 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEOGENOMICS INC CENTRAL INDEX KEY: 0001077183 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 742897368 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 BUSINESS PHONE: 9419231949 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC DATE OF NAME CHANGE: 19990120 3 1 wf-form3_158293041092276.xml FORM 3 X0206 3 2020-02-19 0 0001077183 NEOGENOMICS INC NEO 0001804602 Pedulla Denise E 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913 0 1 0 0 General Counsel Common Stock 41076 D Common Stock 7.85 2016-12-08 2020-12-08 Common Stock 15000.0 D Common Stock 7.52 2018-04-28 2022-04-28 Common Stock 25000.0 D Common Stock 8.03 2019-02-26 2023-02-26 Common Stock 48334.0 D Common Stock 19.6 2020-03-01 2024-03-01 Common Stock 17496.0 D On December 8, 2015, Ms. Pedulla was granted an option to purchase 60,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date. On April 28, 2017, Ms. Pedulla was granted an option to purchase 75,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date. On January 26, 2018, Ms. Pedulla was granted an option to purchase 72,500 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date. On March 1, 2019, Ms. Pedulla was granted an option to purchase 17,496 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date. /s/ Denise E Pedulla 2020-02-28